Iopromide Injection Shortage
Last Updated: May 24, 2024
Status: Current
Products Affected - Description
-
- Ultravist injection, Bayer, 240 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0342-10 - discontinued
- Ultravist injection, Bayer, 300 mg iodine/ mL, 125 mL vial, 1 count, NDC 50419-0344-12 - discontinued
- Ultravist injection, Bayer, 300 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0344-15
- Ultravist injection, Bayer, 370 mg iodine/ mL, 200 mL vial, 1 count, NDC 50419-0346-20 - discontinued
Reason for the Shortage
-
- Bayer did not provide a reason for the shortage. Bayer discontinued Ultravist 300 mg in 125 mL vials and 370 mg in 200 mL vials.
Available Products
-
- Ultravist injection, Bayer, 300 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0344-10
- Ultravist injection, Bayer, 300 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0344-05
- Ultravist injection, Bayer, 370 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0346-10
- Ultravist injection, Bayer, 370 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0346-15
- Ultravist injection, Bayer, 370 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0346-05
Estimated Resupply Dates
-
- Bayer has Ultravist 300 mg of iodine/mL in 150 mL vials on back order and the company cannot estimate a release date.
Updated
Updated May 24, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 24, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.